Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study.
Minicozzi, P
; Kaleci, S; Maffei, S; Allemani, C
; Giacomin, A; Caldarella, A; Iachetta, F; Fusco, M; Tumino, R; Vicentini, M; +4 more...Falcini, F; Cesaraccio, R; Ponz de Leon, M; Sant, M and
(2013)
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study.
European journal of public health, 24 (1).
pp. 98-100.
ISSN 1101-1262
DOI: 10.1093/eurpub/ckt056
We analysed presentation, treatment and survival in a representative population-based sample of 3753 Italian colorectal cancer cases, diagnosed 2003-05: 70% were >65 years, 44% stage I-II, 27% stage IV and 92% received surgery. Chemotherapy was given to 58% of stage III colon cases, radiotherapy to 25% of rectal cases. Four percent of surgical cases underwent endoscopic polypectomy, and in 57% ≥11 lymph nodes were examined. Five-year relative survival was good (60%), independent of sex and site. Adherence to treatment guidelines was satisfactory, but wider use of faecal blood testing and colonoscopy will anticipate stage at diagnosis and likely improve survival.
Item Type | Article |
---|---|
ISI | 330838200021 |
Date Deposited | 18 Mar 2014 21:22 |
ORCID: https://orcid.org/0000-0002-7273-7947
ORCID: https://orcid.org/0000-0003-4871-3766